ARCHIVES

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

This article is from The Cancer Letter archive.

Vol. 30 No. 24 | June 11, 2004

Download PDF Visit The Full Archive

Related Articles

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed

August 20, 1976

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

June 10, 1983